CIRCULATING CYTOKINES AND GASTRIN LEVELS IN ASYMPTOMATIC SUBJECTS INFECTED BY HELICOBACTER PYLORI (H. PYLORI)

REFERENCES

• Osella A. R., Leoci C., Misciagna G., Di A. Leo. Decreasing Helicobacter prevalence in an area of Southern Italy. Ital J Gastroenterol 1996; 28(suppl 2)A214, (Abstr.).
   Google Scholar
• Di A. Leo, Messa C., Russo F., Linsalata M., Amati L., Caradonna L., Pece S., Pellegrino N. M., Caccavo D., Antonaci S., Jirillo E. H. pylori infection and host cell response. Immunopharmacol Immunotoxicol 1999; 21: 803
   PubMed Web of Science ®Google Scholar
• Linsalata M., Russo F., Notarnicola M., Berloco P., Di A. Leo. Polyamine profile in human gastric mucosa infected by H. pylori. Ital J Gastroenterol Hepatol 1998; 30: 484
   PubMed Web of Science ®Google Scholar
• Russo F., Messa C., Amati L., Caradonna L., Leoci C., Di G. Matteo, Jirillo E., Di A. Leo. The influence of H. pylori eradication on the gastric mucosalcontent of Epidermal Growth factor, Transforming Growth Factor-α, andtheir common receptor. Scand J Gastroenterol 1998; 33: 271
   PubMed Web of Science ®Google Scholar
• Levi S., Beardshall K., Playford R., Ghosh P., Haddad G., Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; 1: 1167
   PubMed Web of Science ®Google Scholar
• Messa C., Di A. Leo, Greco B., Caradonna L., Amati L., Linsalata M., Giorgio I., Jirillo E. Successful eradicating treatment of Helicobacter pylori in patientswith chronic gastritis: gastric levels of cytokines, epidermal growth factorand polyamines before and after therapy. Immunopharmacol Immunotoxicol 1996; 18: 1
   PubMed Web of Science ®Google Scholar
• Lehmann F. S., Stalder G. A. Hypotheses on the role of cytokines in peptic ulcer disease. Eur J Clin Invest 1998; 28: 511
   PubMed Web of Science ®Google Scholar
• Noach L. A., Bosma N. B., Jansen J., Hoek F. J., van Deventer S. J., Tytgat G. N. Mucosal tumor necrosis factor-alpha, interleukin-1-beta, andinterleukin-8 production in patients with Helicobacterpylori infection. Scand J Gastroenterol 1994; 29: 425
   PubMed Web of Science ®Google Scholar
• Crabtree J. E., Wyatt J. I., Trejdosiewicz L. K., Peichl P., Nichols P. H., Ramsay N., Primrose J. N., Lindley I. J. Interleukin-8 expression in Helicobacter pylori infected, normal,and neoplastic gastroduodenal mucosa. J Clin Pathol 1994; 47: 61
   PubMed Web of Science ®Google Scholar
• Ernst P B., Crowe S E., Reyes V E. How does Helicobacter pylori cause mucosal damage? The inflammatoryresponse. Gastroenterology 1997; 113(Suppl. 6)S35
   Web of Science ®Google Scholar
• Crabtree J. E., Lindley I. J. Mucosal interleukin-8 and Helicobacterpylori-associated gastroduodenal disease. Eur J Gastroenterol Hepatol 1994; 6: S33
   Web of Science ®Google Scholar
• Imanishi J., Kita M., Yamaoka Y., Sawai N., Tanahashi T., Kodama T. Role of cytokines in the pathogenesis of gastrointestinal diseasesassociated with Helicobacter pylori infection. C R Seances Soc Biol Fil 1998; 192(5)991
   PubMedGoogle Scholar
• Ernst P. Review article: the role of inflammation in the pathogenesisof gastric cancer. Aliment Pharmacol Ther 1999; 13(Suppl 1)13
   PubMed Web of Science ®Google Scholar
• Moss S. F., Legon S., Davies J., Calam J. Cytokine gene expression in Helicobacter pylori associated antralgastritis. Gut 1994; 35(11)1567
   PubMed Web of Science ®Google Scholar
• Curfs J. A.A.J., Meis J. F.G.M., Hoogkamp-Korstanje J. A.A. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev, 1997 1997; 10: 742
   PubMed Web of Science ®Google Scholar
• Chen C. C., Manning A. M. TGFβ1, IL-10 and IL-4 differentially modulate the cytokine-inducedexpression of IL-6 and IL-8 in human endothelial cells. Cytokine 1996; 8: 58
   PubMed Web of Science ®Google Scholar
• Bodger K., Wyatt J. I., Heatley R. V. Gastric mucosal secretion of interleukin-10: relations to histopathology,Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut 1997; 40: 739
   PubMed Web of Science ®Google Scholar
• D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M., Trinchieri G. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-γproduction by suppressing natural killer cell stimulatory factor IL-12 synthesisin accessory cells. J Exp Med 1993; 178: 1041
   PubMed Web of Science ®Google Scholar
• Sawai N., Kita M., Kodama T., Tanahashi T., Yamaoka Y., Tagawa Y., Iwakura Y., Imanishi J. Role of gamma interferon in Helicobacter pylori-induced gastricinflammatory responses in a mouse model. Infect Immun 1999; 67: 279
   PubMed Web of Science ®Google Scholar
• Karttunnen R. A., Karttunen T. J., Yousfi M. M., el-Zimaity H. M., Graham D. Y., el-Zaatari F. A. Expression of mRNA for interferon-gamma, interleukin-10, andinterleukin-12 (p40) in normal gastric mucosa and in mucosa infected withHelicobacter pylori. Scand J Gastroenterol 1997; 32: 22
   PubMed Web of Science ®Google Scholar
• Beales I. L., Calam J. Helicobacter pylori infection and tumour necrosis factor-alphaincrease gastrin release from human gastric antral fragments. Eur J Gastroenterol Hepatol 1997; 9: 773
   PubMed Web of Science ®Google Scholar
• Calam J., Gibbons A., Healey Z. V., Bliss P., Arebi N. How does Helicobacter pylori cause mucosal damage? Its effecton acid and gastrin physiology. Gastroenterology 1997; 113(Suppl 6)S43
   Web of Science ®Google Scholar
• Buckley M. J., Scanlon C., McGurgan P., O'Morain C. A. A validated dyspepsia symptom score. Ital J Gastroenterol Hepatol 1997; 29: 495
   PubMed Web of Science ®Google Scholar
• Smith J. T., Pounder R. E., Nwokolo C. U., Lanzon-Miller S., Evans D. G., Graham D. Y., Evans D. J. Jr. Inappropriate hypergastrinaemia in asymptomatic healthy subjectsinfected with Helicobacter pylori. Gut 1990; 31(5)522
   PubMed Web of Science ®Google Scholar
• Peterson W L. Gastrin and acid in relation to Helicobacter pylori. Aliment Pharmacol Ther 1996 1996; 10(Suppl 1)97
   PubMed Web of Science ®Google Scholar
• Mulholland G., Ardill J. E., Fillmore D., Chittajallu R. S., Fullarton G. M., McColl K. E. Helicobacter pylori related hypergastrinaemia is the resultof a selective increase of gastrin 17. Gut 1993; 34: 757
   PubMed Web of Science ®Google Scholar
• Blaser M J. Hypotheses on the pathogenesis and natural history of Helicobacterpylori-induced inflammation. Gastroenterology 1992; 102: 720
   PubMed Web of Science ®Google Scholar
• Denizot Y., Sobhani I., Rambaud J. C., Lewin M., Thomas Y., Benveniste J. Paf-acether synthesis by Helicobacter pylori. Gut 1990; 31: 1242
   PubMed Web of Science ®Google Scholar
• Lindholm C., Quiding-Järbrink M., Lönroth H., Hamlet A., Svennerholm A. M. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66(12)5964
   PubMed Web of Science ®Google Scholar
• Jirillo E., Pece S., Pellegrino N. M., Di A. Leo, Russo F., Linsalata M., Messa C., Amati L., Caradonna L., Moran A. P., Caccavo D. The role of H. pylori LPS in the pathogenesis of H. pylori-relatedgastropathy. J Endotoxin Res 1999; 5: 222
   Google Scholar
• Murakami M., Saita H., Teramura S., Dekigai H., Asagoe K., Kusaka S., Kita T. Gastric ammonia has a potent ulcerogenic action on the rat stomach. Gastroenterology 1993; 105(6)1710
   PubMed Web of Science ®Google Scholar
• Beales I., Blaser M. J., Srinivasan S., Calam J., Pérez-Pérez G. I., Yamada T., Scheiman J., Post L., Del J. Valle. Effect of Helicobacter pylori products and recombinant cytokineson gastrin release from cultured canine G cells. Gastroenterology 1997; 113(2)465
   PubMed Web of Science ®Google Scholar
• Moss S., Calam J. Helicobacter pylori and peptic ulcers: the present position. Gut 1992; 33: 601
   PubMed Web of Science ®Google Scholar